Novartis’ psoriasis drug allows some patients to go into remission
March 21, 2017Research and Development Cosentyx, Novartis, psoriasis
Novartis released data on patient’s reaction to Cosentyx for the treatment of psoriasis, finding that as many as 21% of …
Asia-Pacific NSCLC market to more than double to $6.2bn by 2023
March 21, 2017Manufacturing and Production, Research and Development, Sales and Marketing BMS, Eli Lilly, MSD, NSCLC, Yervoy, keytruda, opdivo
New research from intelligence provider GBI Research has indicated that the non-small cell lung cancer (NSCLC) market in the Asia-Pacific …
Lilly’s breast cancer drug meets primary endpoint
March 21, 2017Manufacturing and Production, Research and Development CDK 4/6 inhibitors, Eli Lilly, abemaciclib
Eli Lilly has announced that its trial of abemaciclib, in combination with fulvestrant, had met its primary endpoint of progression-free …
India aims to become “a global innovation hub” for biotechs by 2020
March 21, 2017Manufacturing and Production, Research and Development India, biotech
The Indian Government has announced its intention to transform the nation into a hub for global biotech activity via its …
Biogaran acquires production foothold in Nigeria with Swipha acquisition
March 21, 2017Manufacturing and Production, Sales and Marketing Biogaran, Swipharma
Biogaran, the French generic manufacturer that is a subsidiary of Servier, has acquired a foothold in Nigeria with a 95% …
Array BioPharma in disarray over withdrawal of NDA
March 20, 2017Manufacturing and Production, Sales and Marketing Array Biopharma
Array BioPharma has announced that it has pulled its new drug application (NDA) for its drug, binimetinib, for the treatment …
Genentech plans second Phase 3 Alzheimer’s trial following endpoint failures
March 20, 2017Research and Development, Sales and Marketing Alzheimer's, Genentech, Roche
Genentech, Roche’s biotech group, has announced its plans to conduct a second Phase 3 study for crenezumab, its anti-Abeta antibody …
China proposes ways to speed up approval for imported drugs
March 20, 2017Sales and Marketing China, imported drugs
It can currently take up to three or four years for a new drug to reach market in China, slowing …
Pakistan’s problem with diabetes – with 7 million diabetics
March 20, 2017Medical Communications, Sales and Marketing Pakistan, Sanofi, diabetes
Pakistan is facing an increasing problem with people suffering from diabetes. At a recent conference, the 4th International Diabetes Conference, …
UK biotech Pulmocide secures $30m for inhalable lung disease therapies
March 20, 2017Research and Development, Sales and Marketing pulmocide, pulmonary aspergillosis, respiratory syncytial virus
Pulmocide, a UK biotech run by a former GlaxoSmithKline scientists and based in London, has secured $30.4 million in Series …
Pregnancy test pill used through 60s & 70s connected with birth defects
March 20, 2017Medical Communications, Sales and Marketing Bayer, Primodos
A pregnancy test, named Primodos, which was taken by 1.5 million British mothers and was linked to birth defects, may …
Top Ten most popular articles on Pharmafile.com this week
March 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
As another week comes and goes, waves were sent through the industry as Trump announced his pick as the new …
Enhancing scientific acumen in the pharma boardroom
March 17, 2017Medical Communications R&D
Dana M. Krueger and Neha Rajdev, of Russell Reynolds, discuss the importance of a scientific background in the boardrooms of …
FDA warns API manufacturer about river water as ingredient
March 17, 2017Manufacturing and Production, Medical Communications Badrivishal Chemicals & Pharmaceuticals, FDA, India
The FDA has issued Badrivishal Chemicals & Pharmaceuticals a warning letter regarding numerous violations of manufacturing codes. The most worrying …
Ex-Novartis employee found not guilty of deceitful drug advertising
March 17, 2017Medical Communications, Sales and Marketing Diovan, Novartis, legal
A Tokyo court has ruled finding ex-Novartis employee Nobuo Shirahashi and the company’s Tokyo-based sales arm Novartis Pharma KK not …
AstraZeneca hit with second blow on $2.7 billion drug
March 17, 2017Medical Communications AstraZeneca, FDA, hyperkalaemia
AstraZeneca paid $2.7 billion for ZS Pharma, back in 2015, with the desire to get its hands on the company’s …
Biogen swoops to appoint Ex-Roche Vice President
March 16, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen
Biogen have appointed Anirvan Ghosh to the position of Senior Vice President of research and Early Development. Ghosh is slated …
NICE reverses decision on medication for relapsing multiple sclerosis
March 16, 2017Sales and Marketing Biogen, zinbryta
The current topic of discussion regarding NICE is how its recent changes will impact patient access to medicine but, away …
The rising threat of antibiotic resistance
March 16, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance
Last month, researchers from the University of California, Los Angeles (UCLA) revealed findings that showed that utilising antibiotics in combination …
NICE drug expense limit of £20 million could cause treatment delays
March 16, 2017Medical Communications, Sales and Marketing NHS England, NICE, fast-track appraisal process, rare disease
NICE has released its decision on the fast-track approval process and other changes that will be brought through at the …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
